Oya Guven, MD
Kırklareli, Center, 39000, Turkey (Türkiye)
NCT Number: NCT06663462
This study compared EzPAP and noninvasive treatments of hypercapnic COPD attacks.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Kırklareli, Center, 39000, Turkey (Türkiye)
In this study, the effectiveness of NIV and EzPAP treatments was compared in patients admitted to the emergency department due to hypercapnic COPD exacerbation. Blood gas was taken at the 4th and 24th hours of treatment to evaluate the effectiveness.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Clinical diagnosis of Chronic obstructive pulmonary disease Dyspnea
Exclusion criteria
Cardiac failure Dead
Time frame: 24 hours
Carbon dioxide height, low bicarbonate and presence acidosis measure in the blood gas
Kırklareli University
Other
EzPAP Therapy Versus Non-invasive Ventilation for Hypercapnic Chronic Obstructive Pulmonary Disease Exacerbataion: a Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05712330
Central Nervous System Diseases, Motor Neuron Disease
Amiens, Picardie, France
View Trial DetailsNCT04694638
ARDS, COVID-19
Rochester, Minnesota, United States
View Trial DetailsNCT03385421
Non Invasive Ventilation
Grenoble, France
View Trial DetailsNCT02796599
Behavior, Chronic Disease
Bois-Guillaume, France
View Trial Details